Tobira Therapeutics
AcquiredSouth San Francisco, United States · Founded 2006
- Headquarters
- South San Francisco, California
- Employees
- 11–50
- Founded
- 2006
- Business Model
- B2B
- Last Round
- Venture RoundAug 2014
- Rounds
- 1
About
Tobira Therapeutics was a clinical-stage biopharmaceutical company founded in 2006 and headquartered in South San Francisco, California, focused on developing and commercializing therapeutics for liver disease, including non-alcoholic steatohepatitis (NASH), inflammation, fibrosis, and HIV. The company traded on Nasdaq under the ticker TBRA before being acquired by Allergan in 2016 for approximately $1.7 billion, expanding Allergan's global gastrointestinal R&D pipeline.
Summary
Tobira Therapeutics is a Biotech company based in South San Francisco, United States, founded in 2006. Its most recent funding was a Venture Round round in Aug 2014. Investors include Allergan.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2016
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...